Patients using 2-adrenergic receptors antagonists, calcium channel blockers, angiotensin converting enzyme inhibitors, or noted to have dysrhythmias on the electrocardiogram(ECG), a body weight of more than 120 kg, or height less than 150 cm were excluded from the study. Standard monitoring was used, including noninvasive arterial blood pressure, ECG, heart rate (HR) and pulseoximetry (Spo2). The total 46 patients were randomly divided into two groups of 23 patients each according to a computer generated random table. Group B (n=80) patients received 15mg of bupivacaine & 1 ml of NS and Group D (n=80) patients received bupivacane 15mg & 10 µg. Group allocation was done by an assistant who was unaware of the study protocol and was not involved in the study.
 The total 46 patients were randomly divided into two groups of 23 patients each.  Group B -inj 0.5 % hyperbaric bupivacaine 15mg + 1ml of NS  Group D -inj 0.5 % hyperbaric bupivacaine 15mg + 1 ml of Dexmedetomidine (10μg), diluted with NS Total volume of Drug was 4 ml in both the groups.
Anaesthetic technique
Patients were premedicated with tab. alprazolam 0.25 mg and tab. Ranitidine 150 mg the night before the surgery. All patients were kept fasting for 8 hours prior to surgery. On arrival to operation theatre routine monitoring was started and base line vital parameters of heart rate, systemic arterial pressure including systolic, diastolic and mean arterial pressure, arterial oxygen saturation (SpO2), and ECG were recorded. An intravenous line was secured and Ringer lactate was given at rate of 6-8 ml/kg. All patients received premedication of intravenous Inj. Midazolam (0.02mg/kg) and inj. glycopyrrolate (0.01mg/kg)..
After preparation with the patient in sitting position spinal anaesthesia was performed at L3-L4 level through a midline approach with quincke needle. Study group B patients were given bupivacaine 15mg & 1ml of NS (total volume 4 ml) and group D bupivacaine 15mg & 10 μg dexmedetomidine(total volume 4 ml). Study medication was prepared by an anaesthesiologist who was blinded to the randomization schedule.the anaesthesiologist performing block recorded baseline vitals preoperatively,every 3 min for first 15 min,then every 5 min until patient discharged from PACU.sensory dermatome was assessed by pinprick & motor by modified bromage score
II.
Bromage Scale For Motor Blockade The Hemodynamic changes observed as abnormal findings during the study were defined as follows :  Hypotension was defined as SBP < 20% of baseline value or < 90 mm Hg, whichever was lower.  Hypertension was defined as SBP > 20% of baseline value or > 140 mm Hg whichever was higher.  Tachycardia was defined as heart rate >100/minute.  Bradycardia was defined as heart rate < 50/minute After completion of surgery patients transferred to post anaesthesia care unit and monitored for any hemodynamic changes or any other adverse effects.
III. Results
 The data recorded in tabulated manner and was analyzed using Microsoft Excel and SPSS software version 16.0 for windows.  Statistical analysis done using independent student 't' test for parametric data and Chi square test for nonparametric variables.  A 'p' value of less than 0.05 was considered statistically significant.
Out of 46 patients one patient from group B & two from group D were considered as failure.43 patients completed study protocol and included in data.the onset of block & duration is given in Table 1 .The various vitals monitoring before during and after procedure are arranged in table2. 
IV. Conclusion
 Dexmedetomidine when used as an adjunct to bupivacaine in spinal anaesthesia helped in keeping the patient hemodynamically stable throughout the surgery.  Intrathecal dexmedetomidine did not potentiate the effect of bupivacaine on blood pressure. This may be explained by the mechanism local anaesthetics affect blood pressure. Local anaesthetics reduce blood pressure by decreasing sympathetic outflow. Sympathetic blockade produced by intrathecal dexmedetomidine does not decrease blood pressure further presumably because the blockade produced by bupivacaine is nearly maximum.  The intrathecal use of dexmedetomidine is off label. Highest dose of intrathecal dexmedetomidine used in animal studies was 100 µg .Konakci and colleagues reported white matter injury in rats when high dose epidural dexmedetomidine (6 µg/kg) was used alone; however,  subsequently Brummett and co-workers demonstrated no injury and a protective effect when doses of 26-40 µg/kg were used perineurally.  In humans the largest epidural dose used was 2µg/kg (and the largest intrathecal dose used was 10 µg .  Although no major neurological complications have been reported so far, larger studies are required to rule out any short term or long term adverse effects.
